Prosecution Insights
Last updated: October 02, 2026

Examiner: SODERQUIST, ARLEN

Tech Center 3700 • Art Units: 1677 1699 1777 1797 1798 3774

This examiner grants 60% of resolved cases

Analysis

Arlen Soderquist works in Tech Center 3700 and Art Unit 1677, where they have resolved 927 cases. The examiner has an allowance rate of 59.7 percent, which indicates the frequency of patent grants. The median days to allowance is 1197, providing a benchmark for the duration of the prosecution process for the 927 cases in the record. This 1197-day period is a factor for applicants to consider when planning their prosecution strategy.

The interview lift is 26.3 percent, showing that interviews are effective at increasing the likelihood of allowance. This 26.3 percent lift is an increase over the 59.7 percent baseline allowance rate. Practitioners should consider the 1197-day median pendency and the positive impact of interviews when developing their strategy. The data suggests that direct engagement through interviews can enhance the 59.7 percent probability of success.

With 927 cases resolved, the 59.7 percent allowance rate and 26.3 percent interview lift are key metrics for Art Unit 1677. The 1197-day median timeline to allowance is an important factor for managing expectations. These figures provide a factual basis for setting expectations for the duration of the process and help in refining the approach to verbal advocacy.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

59.7%
Allow Rate
-10.3% vs TC avg
946
Total Applications
+26.3%
Interview Lift
1197
Avg Prosecution Days
Based on 927 resolved cases, 2023–2026

Rejection Statute Breakdown

1.8%
§101 Eligibility
15.0%
§102 Novelty
43.2%
§103 Obviousness
31.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18411053 COMPOUND AND LABELED BIOLOGICAL SUBSTANCE USING THE SAME Non-Final OA FUJIFILM Corporation
18703915 USE OF BIOMARKERS IN DIAGNOSING AND TREATING LUPUS NEPHRITIS Non-Final OA The Johns Hopkins University
17380423 DETECTION OF HEMOLYSIS USING A CHROMATOGRAPHIC DETECTION PAD Non-Final OA Siemens Healthcare Diagnostics Inc.
18684133 MOLECULE DETECTIONS Non-Final OA Hewlett-Packard Development Company, L.P.
18682535 AGRICULTURAL SAMPLE HANDLING SYSTEM AND RELATED METHODS Non-Final OA Precision Planting LLC
18337018 LC-MS METHOD FOR DETECTING AND QUANTIFYING 11-OXYGENATED STEROIDS Final Rejection Roche Diagnostics Operations, Inc.
18616847 METHOD FOR ANALYZING SPECIMEN Non-Final OA SYSMEX CORPORATION
18249752 METHODS FOR MEASURING DYSTROPHIN IN TISSUE SAMPLES Non-Final OA PFIZER INC.
18695414 QUANTIFICATION METHOD OF POLYSORBATE IN AQUEOUS FORMULATIONS Non-Final OA Boehringer Ingelheim International GmbH
17998207 DEVICE FOR CHEMILUMINESCENCE ANALYSIS Final Rejection Analytik Jena GmbH

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month